Source: Annual Congress 2001 - Clinical asthma: miscellaneous
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Utkusavas, C. Cuhadaroglu, M. Erelel, E. Kiyan, O. Arseven, Z. Kilicaslan, F. K. Erkan, T. Ece, L. Tabak (Istanbul, Turkey). Prescription rates for various classes of COPD & asthma medication in Turkey. Eur Respir J 2001; 16: Suppl. 31, 2868

Member's Comments

No comment yet.

Related content which might interest you: Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study Source: International Congress 2014 – New insights into the epidemiology of COPD Year: 2014 Costs of COPD and asthma in Sweden Source: Eur Respir J 2004; 24: Suppl. 48, 701s Year: 2004 Oral corticosteroid prescription patterns in asthma care in Italy Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 The drug costs associated with COPD prescription medicine in Denmark Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012 Real-world medication use patterns in stable COPD patients from Romania Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Prescribing patterns for UK patients commencing first maintenance therapy for COPD Source: International Congress 2014 – COPD markers Year: 2014 Differences in adherence to common inhaled medications in COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014 Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Changes in demographics and asthma characteristics of the hospitalized asthma exacerbations in Barcelona in the 2000 decade Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Hospital readmissions and social deprivation in asthma and COPD Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Antibiotics prescriptions increased medical costs for COPD exacerbations. Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Medication use in multi-symptom asthma: Results from the West Sweden asthma study Source: Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics Year: 2011 Global asthma physician & patient (GAPP) survey: satisfaction with current asthma medications in Europe – adult findings Source: Annual Congress 2006 - New developments in the management of asthma Year: 2006 The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Cost of asthma in patients treated with national asthma guideline in Turkey Source: Eur Respir J 2003; 22: Suppl. 45, 481s Year: 2003 Predictors of excessive short-acting beta2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database. Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020